Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Paragon 28, Inc. Common Stock (NY:FNA)

13.09 UNCHANGED
Last Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Paragon 28, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio
From Paragon 28, Inc.
Via Business Wire
Preview: Paragon 28's Earnings
 
Via Benzinga
Paragon 28: Q1 Earnings Insights
 
Via Benzinga
Looking Into Paragon 28's Return On Capital Employed
 
Via Benzinga
Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at Upcoming Investor Conferences
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report Third Quarter Financial Results on November 7, 2023
From Paragon 28, Inc.
Via Business Wire
Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report Second Quarter Financial Results on August 2, 2023
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference
From Paragon 28, Inc.
Via Business Wire
Paragon 28 Launches Phantom® Metatarsal Shortening System
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report First Quarter Financial Results on May 4, 2023
From Paragon 28, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
 
Via Benzinga
Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
From Paragon 28, Inc.
Via Business Wire
Paragon 28 to Present at Upcoming Investor Conferences
From Paragon 28, Inc.
Via Business Wire
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
From Paragon 28, Inc.
Via Business Wire
Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
From Paragon 28, Inc.
Via Business Wire
7 Undiscovered Stocks to Watch for the Next Big Thing
If you have a tolerance for risk and are willing to look for hot stocks to trade, here are some to the top stocks to watch. 
Via InvestorPlace
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.